HTG Molecular Diagnostics, Inc. Form SC 13D: Beneficial ownership report (active)
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2022-12-07: Form SC 13D/A; Description AMENDMENT NO. 2; Document r126220sc13da2.htm.
- 2022-12-02: Form SC 13D/A; Description AMENDMENT NO. 1; Document f121223sc13da1.htm.
- 2022-08-05: Form SC 13D; Description Beneficial ownership report (active); Document g84220sc13d.htm.
- 2018-02-13: Form SC 13D/A; Description Beneficial ownership report (active); Document htg.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2022-12-07 | SC 13D/A | AMENDMENT NO. 2 | r126220sc13da2.htm | |
| 2022-12-02 | SC 13D/A | AMENDMENT NO. 1 | f121223sc13da1.htm | |
| 2022-08-05 | SC 13D | Beneficial ownership report (active) | g84220sc13d.htm | |
| 2018-02-13 | SC 13D/A | Beneficial ownership report (active) | htg.htm | |
| 2017-09-01 | SC 13D/A | Beneficial ownership report (active) | glaxo-htg13da3_0831.htm | |
| 2017-08-29 | SC 13D/A | SC 13D/A | d239917dsc13da.htm | |
| 2017-08-23 | SC 13D/A | SC 13D/A | d406297dsc13da.htm | |
| 2017-07-20 | SC 13D/A | SC 13D/A | d426244dsc13da.htm | |
| 2017-07-20 | SC 13D/A | Beneficial ownership report (active) | glaxo-htg13da2_0719.htm | |
| 2017-03-31 | SC 13D/A | SC 13D/A | d369311dsc13da.htm | |
| 2017-03-29 | SC 13D/A | Beneficial ownership report (active) | gskhtgmsc13da1-0328.htm | |
| 2017-03-10 | SC 13D/A | SC 13D/A | d259090dsc13da.htm | |
| 2015-05-15 | SC 13D | Beneficial ownership report (active) | glaxo-htg13d_0514.htm | |
| 2015-05-13 | SC 13D | SC 13D | d923712dsc13d.htm |